Deutsche Bank
TEVA icon

Deutsche Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Deutsche Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Buy
3,037,225
+207,255
+7% +$6.9M 0.03% 497
2026
Q1 		$85.2M Buy
2,829,970
+318,314
+13% +$10.2M 0.03% 521
2025
Q4 		$78.4M Buy
2,511,656
+118,755
+5% +$2.93M 0.03% 523
2025
Q3 		$48.3M Buy
2,392,901
+156,864
+7% +$2.76M 0.02% 633
2025
Q2 		$37.5M Sell
2,236,037
-353,570
-14% -$5.71M 0.01% 658
2025
Q1 		$39.8M Buy
2,589,607
+375,064
+17% +$6.7M 0.02% 670
2024
Q4 		$48.8M Sell
2,214,543
-2,710,449
-55% -$49.3M 0.02% 646
2024
Q3 		$88.7M Buy
4,924,992
+1,697,076
+53% +$29.7M 0.04% 436
2024
Q2 		$52.5M Buy
3,227,916
+1,085,584
+51% +$16.7M 0.02% 538
2024
Q1 		$30.2M Buy
2,142,332
+134,969
+7% +$1.7M 0.01% 695
2023
Q4 		$21M Sell
2,007,363
-294,823
-13% -$2.75M 0.01% 789
2023
Q3 		$23.5M Sell
2,302,186
-643,658
-22% -$5.99M 0.02% 667
2023
Q2 		$22.2M Buy
2,945,844
+508,615
+21% +$4.12M 0.01% 744
2023
Q1 		$21.6M Sell
2,437,229
-175,300
-7% -$1.73M 0.01% 748
2022
Q4 		$23.8M Buy
2,612,529
+83,608
+3% +$730K 0.01% 715
2022
Q3 		$20.4M Sell
2,528,921
-281,334
-10% -$2.49M 0.01% 753
2022
Q2 		$21.1M Sell
2,810,255
-95,339
-3% -$831K 0.01% 768
2022
Q1 		$27.3M Sell
2,905,594
-142,108
-5% -$1.19M 0.01% 754
2021
Q4 		$24.4M Buy
3,047,702
+138,056
+5% +$1.25M 0.01% 794
2021
Q3 		$28.3M Buy
2,909,646
+901,421
+45% +$8.44M 0.01% 770
2021
Q2 		$19.9M Buy
2,008,225
+678,527
+51% +$7.18M 0.01% 901
2021
Q1 		$15.3M Buy
1,329,698
+492,679
+59% +$5.65M 0.01% 997
2020
Q4 		$8.08M Sell
837,019
-50,973
-6% -$488K ﹤0.01% 1134
2020
Q3 		$8M Sell
887,992
-104,524
-11% -$1.11M 0.01% 1056
2020
Q2 		$12.2M Sell
992,516
-85,911
-8% -$972K 0.01% 884
2020
Q1 		$9.68M Buy
1,078,427
+145,795
+16% +$1.49M 0.01% 927
2019
Q4 		$9.14M Sell
932,632
-874,025
-48% -$7.8M 0.01% 1130
2019
Q3 		$12.4M Sell
1,806,657
-2,927,356
-62% -$22.4M 0.01% 979
2019
Q2 		$43.7M Buy
4,734,013
+3,127,190
+195% +$37.7M 0.03% 627
2019
Q1 		$25.2M Sell
1,606,823
-1,295,396
-45% -$22.8M 0.02% 871
2018
Q4 		$44.7M Buy
2,902,219
+1,036,109
+56% +$21.2M 0.03% 544
2018
Q3 		$40.2M Sell
1,866,110
-2,505,169
-57% -$58.2M 0.02% 746
2018
Q2 		$106M Sell
4,371,279
-963,821
-18% -$19.7M 0.05% 371
2018
Q1 		$91.2M Buy
5,335,100
+3,135,702
+143% +$61.2M 0.04% 426
2017
Q4 		$41.7M Buy
2,199,398
+155,907
+8% +$2.35M 0.03% 617
2017
Q3 		$36M Buy
2,043,491
+461,655
+29% +$10.4M 0.02% 685
2017
Q2 		$52.5M Sell
1,581,836
-1,119,877
-41% -$34.7M 0.04% 502
2017
Q1 		$86.7M Buy
2,701,713
+698,495
+35% +$23.8M 0.06% 343
2016
Q4 		$72.6M Buy
2,003,218
+1,380,149
+222% +$55.1M 0.06% 363
2016
Q3 		$28.7M Sell
623,069
-182,121
-23% -$9.5M 0.02% 743
2016
Q2 		$40.4M Sell
805,190
-1,434,942
-64% -$76.4M 0.03% 610
2016
Q1 		$120M Sell
2,240,132
-321,253
-13% -$18.8M 0.09% 253
2015
Q4 		$168M Buy
2,561,385
+166,054
+7% +$10.3M 0.12% 199
2015
Q3 		$135M Sell
2,395,331
-861,975
-26% -$55.9M 0.1% 220
2015
Q2 		$193M Buy
3,257,306
+1,241,114
+62% +$76.6M 0.12% 211
2015
Q1 		$126M Buy
2,016,192
+57,297
+3% +$3.33M 0.08% 299
2014
Q4 		$113M Sell
1,958,895
-319,168
-14% -$17.8M 0.07% 322
2014
Q3 		$122M Sell
2,278,063
-622,916
-21% -$33M 0.08% 293
2014
Q2 		$152M Buy
2,900,979
+286,168
+11% +$14.6M 0.1% 236
2014
Q1 		$138M Buy
2,614,811
+168,034
+7% +$7.77M 0.1% 247
2013
Q4 		$98.1M Buy
2,446,777
+762,666
+45% +$30M 0.07% 315
2013
Q3 		$63.6M Buy
1,684,111
+262,020
+18% +$10.2M 0.05% 421
2013
Q2 		$55.7M Buy
+1,422,091
New +$55.4M 0.05% 431

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Deutsche Bank's TEVA Position: Q2 2026 in Review

Deutsche Bank increased its Teva Pharmaceuticals (TEVA) stake by 7.3% in Q2 2026, buying an estimated $6.9M and bringing the position to 3,037,225 shares worth $103M. The position accounts for 0.03% of the portfolio, ranked #497.

Deutsche Bank first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $193M in Q2 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Deutsche Bank held 3,037,225 shares of Teva Pharmaceuticals worth $103M as of Q2 2026.
  • Deutsche Bank bought 207,255 Teva Pharmaceuticals shares in Q2 2026, an estimated $6.9M.
  • Teva Pharmaceuticals made up 0.03% of Deutsche Bank's portfolio in Q2 2026, its #497 holding.
  • Deutsche Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Teva Pharmaceuticals position peaked at $193M in Q2 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.